1. Home
  2. PRTA vs FFIC Comparison

PRTA vs FFIC Comparison

Compare PRTA & FFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$9.12

Market Cap

495.8M

Sector

Health Care

ML Signal

HOLD

Logo Flushing Financial Corporation

FFIC

Flushing Financial Corporation

HOLD

Current Price

$15.01

Market Cap

557.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTA
FFIC
Founded
2012
1929
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
495.8M
557.3M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
PRTA
FFIC
Price
$9.12
$15.01
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$18.86
N/A
AVG Volume (30 Days)
729.9K
511.6K
Earning Date
02-19-2026
01-27-2026
Dividend Yield
N/A
5.96%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,786,000.00
$143,853,000.00
Revenue This Year
N/A
$113.60
Revenue Next Year
$819.08
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.32
$10.65
52 Week High
$16.67
$17.79

Technical Indicators

Market Signals
Indicator
PRTA
FFIC
Relative Strength Index (RSI) 41.47 36.64
Support Level $8.95 $14.49
Resistance Level $9.47 $15.46
Average True Range (ATR) 0.37 0.56
MACD -0.03 -0.28
Stochastic Oscillator 25.63 21.91

Price Performance

Historical Comparison
PRTA
FFIC

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

Share on Social Networks: